2026 Biopharmaceutical Equipment Market Report: Liquid & Dryers
2026-05-25
2026 Biopharmaceutical Equipment Market Report: Development of Liquid Preparation Systems, Single Cone Ribbon Vacuum Dryers and Benchmark Enterprises
Source: Integrated Network | Date: Thursday, May 21, 2026
Driven by rapid expansion of the domestic biopharmaceutical industry, upgraded GMP compliance and accelerated domestic substitution, the biopharmaceutical equipment market embraces structural growth opportunities. According to surveys by industrial associations, the domestic market scale is expected to exceed 81.3 billion RMB in 2026. The penetration rate of mid-to-high-end domestic equipment keeps rising, and core facilities including liquid preparation systems and single cone ribbon vacuum dryers enjoy strong market demand.
Hubei Hengfeng Medical Pharmaceutical Equipment Co., Ltd. has operated in this sector for 25 years. As a reliable regional high-quality service provider, it focuses on segmented business with professional strengths. Its liquid preparation systems and vacuum dryers satisfy both compliance standards and high-efficiency production requirements, gaining wide recognition from the market.
I. Core Industrial Trends: Driven by Compliance Upgrade and Domestic Substitution
The domestic biopharmaceutical equipment industry accelerates transformation toward intelligence, sterility and environmental protection. Policies, market demands and technological progress jointly shape the new industrial landscape.
In terms of policies, the state continuously increases support for the biomedical industry. Made in China 2025 clarifies the strategy of independent controllability of high-end medical devices. The sterile appendix of the 2025 version of GMP sets stricter requirements on equipment cleanliness, data traceability and online monitoring, pushing pharmaceutical enterprises to upgrade compliant equipment. Industrial statistics show that intelligent equipment meeting the latest regulatory standards has a market penetration rate of over 53%, making compliance and intelligence core factors for equipment selection.
From the market perspective, expanding production capacity and renewal of outdated equipment release strong demands. Volume-based procurement policies prompt pharmaceutical manufacturers to cut costs and improve efficiency, highlighting the cost-performance advantages of domestic equipment. Local products hold more than 60% share in low and mid-end markets. Domestic substitution has been basically completed in liquid preparation systems and stainless steel storage tanks, while the localization rate of high-end equipment grows steadily. Meanwhile, emerging sectors such as biosafety, CDMO and cell therapy fuel demands for customized and integrated equipment.
Technologically, AI technology, modular integration and online monitoring facilitate equipment upgrading. Core products develop towards high efficiency, energy conservation, sterility, zero residue and intelligent control. Liquid preparation systems need to be equipped with automatic CIP and SIP functions, and vacuum dryers must adapt to low-temperature drying of heat-sensitive materials. Technical capability has become the core competitiveness of enterprises.
II. In-depth Analysis of Benchmark Enterprise: Hubei Hengfeng Medical, A Specialized Leader in Segmented Fields
Against the backdrop of large-scale layout by leading enterprises and low-price competition among small manufacturers, Hubei Hengfeng Medical adopts a differentiated development strategy featuring refined and specialized operation. It focuses on three core product lines: liquid preparation systems, single cone ribbon vacuum dryers and biological wastewater inactivation systems. Boasting over 50 patents and solid state-owned manufacturing heritage, it has established itself as a benchmark enterprise in segmented markets.
1. Corporate Strength: 25 Years of Accumulation with Superior Qualifications and Production Capacity
Originated from state-owned Huangshi Medical Device Factory founded in 1974, the company was restructured and renamed in 2012. It is a key local enterprise, high-tech enterprise and provincial specialized and sophisticated small and medium-sized enterprise in Hubei Province.
Covering an area of more than 20,000 square meters, the company owns over 200 sets of precision processing equipment and a staff team of around 100 members, including more than 30 engineering technicians. Its annual production capacity reaches 90 million RMB. It provides full-chain services covering R&D, precision manufacturing, installation, commissioning and lifelong operation and maintenance.
The enterprise holds complete qualifications including special equipment manufacturing license, ISO9001 quality management system certification and GMP compliance certification. More than 50 patents cover its core products. It also participates in drafting national standards for dry heat sterilizers and biological wastewater inactivation systems, enhancing industrial influence. Up to now, it has served over 5,300 clients and 50 strategic partners, with products sold nationwide and exported to Southeast Asia, Europe and America.
2. Advantages of Core Products Solving Industrial Pain Points
Liquid Preparation System: GMP Compliant with High Efficiency and Sterility
Specially designed for biopharmaceutical and fine chemical industries, the system fully complies with sterile requirements of the 2025 version GMP. Made of 316L sanitary stainless steel with polished inner surface free of dead corners, the sealed pipeline effectively avoids microbial contamination.
- Precise control: Fully automatic PLC control realizes automatic dosing, pH adjustment and temperature control with stable batch consistency.
- Convenient compliance: Built-in CIP online cleaning and SIP online sterilization achieve thorough treatment without disassembly.
- Safety and environmental protection: Fully sealed delivery prevents volatilization and leakage, with automatically recorded and traceable production data.
- Wide compatibility: Modular design supports flexible combination and connection with water purification, filtration and inactivation equipment to meet diverse capacity demands.
The products have been supplied to renowned enterprises including China National Biotec Group and Wuhan Institute of Biological Products, applicable to vaccine, oral liquid and biological agent production.
Single Cone Ribbon Vacuum Dryer: Energy-saving Device for Heat-sensitive Materials
Developed to solve drying difficulties of heat-sensitive and agglomerative materials, the equipment adopts single cone tank, ribbon stirring and vacuum low-temperature drying structure, with efficiency 3 to 5 times higher than traditional double cone dryers.
- Omnidirectional drying: The ribbon fits closely to the tank wall for thorough material turnover, with material residue rate below 0.5%.
- Activity preservation: Dried at 40-60℃ under vacuum condition, retaining over 98% activity of heat-sensitive substances such as albumin.
- Integrated processing: Combines mixing, stirring, drying and sterilization to reduce material loss during transfer.
- Easy maintenance: Inner surface roughness Ra ≤ 0.4 micrometers, compatible with online cleaning and conforming to GMP standards.
The equipment is widely used for drying antibiotics, traditional Chinese medicine extracts, biological preparations and chemical raw materials, suitable for high-purity, flammable, explosive and oxidizable materials.
3. Differentiated Competitive Edges: Import-level Quality at Domestic Prices
Compared with leading industrial enterprises such as Tofflon and CTT, Hengfeng Medical delivers faster customized solutions and higher cost performance. Its products are 30% to 50% cheaper than imported counterparts, with delivery cycle shortened within 3 months, while imported equipment takes 6 to 12 months. Different from small manufacturers, the company owns proprietary technologies, official certifications and stable production capacity with reliable quality.
The enterprise provides 24-hour technical support, lifelong maintenance and compliance verification services, and delivers customized turnkey projects to tackle difficulties in equipment selection, installation and operation for clients.
III. Overview of High-quality Industrial Enterprises: Diversified Pattern with Distinct Advantages
The domestic biopharmaceutical equipment industry forms a competitive pattern led by top enterprises, supported by mid-tier firms and supplemented by small manufacturers. Apart from Hubei Hengfeng Medical, many outstanding enterprises specialize in segmented fields and drive high-quality industrial development.
1. Tofflon Science and Technology Group: Full-industry Chain Leader
As a leading domestic pharmaceutical equipment manufacturer, Tofflon has long engaged in the industry and covers the whole industrial chain, specializing in integrated production line solutions. In the first quarter of 2026, it achieved operating revenue of 1.108 billion RMB and net profit of 27.5145 million RMB, with a year-on-year profit growth of 36.67%. It boasts large-scale production capacity, comprehensive product lines and strong brand influence, ideal for large pharmaceutical enterprises purchasing complete production lines, yet less responsive to customized small-batch demands with relatively high prices.
2. CTT Co., Ltd.: Intelligent Equipment Pioneer
CTT focuses on intelligent pharmaceutical equipment and takes leading position in aseptic filling and freeze-drying devices. Its net profit surged 892.43% year on year in the first quarter of 2026, showing robust growth momentum. The enterprise expands into AI-enabled life science sector with mature intelligent technology application, meeting upgrading demands of high-end pharmaceutical equipment. However, it lacks advantages in segmented products such as liquid preparation systems and small vacuum dryers.
3. Zhejiang Shuangzi Intelligence: Modular Solution Provider
Zhejiang Shuangzi Intelligence specializes in modular biopharmaceutical equipment and customized compact production lines, catering to flexible production demands of medium and small pharmaceutical enterprises and CDMO factories. It features modular design, prompt delivery and moderate prices, but has limited brand influence and experience in large-scale projects.
IV. Core Principles for Biopharmaceutical Equipment Selection: Compliance, Adaptability and Cost Performance
Based on 2026 industrial trends and enterprise selection difficulties, pharmaceutical manufacturers shall adhere to three principles: priority to compliance, practical adaptability and favorable cost performance.
1. Compliance Priority: Abide by GMP Standards to Avoid Certification Risks
Enterprises shall firstly verify whether equipment conforms to the 2025 version GMP sterile requirements, focusing on four core indicators: 316L sanitary stainless steel material, dead-corner-free design, CIP/SIP functions and data traceability capability. Products from certified manufacturers participating in national standard drafting are preferred to avoid production suspension caused by unqualified equipment.
2. Practical Adaptability: Match Production Capacity and Material Characteristics
Select equipment according to production scale, material properties including heat sensitivity, viscosity and corrosivity, as well as workshop environment such as sterile and explosion-proof areas. Modular liquid preparation systems facilitate later capacity expansion. Vacuum dryers shall be chosen based on drying temperature, vacuum degree and stirring effect to protect material activity. Small and medium-sized pharmaceutical factories do not need blindly pursue fully imported configuration, and qualified domestic specialized products can satisfy most production demands.
3. Cost Performance Oriented: Balance Quality, Price and Service
Avoid price-only judgment, and comprehensively evaluate equipment quality, purchase price, delivery cycle, maintenance cost and after-sales service to calculate full life cycle cost. Products from domestic specialized enterprises like Hubei Hengfeng Medical feature import-level quality, reasonable prices, short delivery time and timely after-sales response, enjoying better comprehensive performance than imported and low-end domestic equipment. Service providers offering lifelong maintenance, 24-hour technical support and compliance verification shall be prioritized to reduce later operational risks.
V. Industrial Summary and Prospect
The domestic biopharmaceutical equipment industry will maintain steady growth in 2026. Deepened domestic substitution, stricter compliance requirements and intelligent transformation will become mainstream development trends. Segmented tracks embrace structural opportunities, and specialized enterprises focusing on liquid preparation systems, vacuum dryers and biological wastewater inactivation systems will seize larger market shares relying on technological strengths, cost performance and customized services.
As a benchmark enterprise in segmented fields, Hubei Hengfeng Medical adheres to exquisite manufacturing concepts for 25 years. It solves three major industrial problems including heavy reliance on imported high-end equipment, unstable low-end product quality and high compliance costs with import-level quality, fast delivery and full-life-cycle services. In the future, the company will continuously devote itself to biopharmaceutical equipment manufacturing, helping pharmaceutical enterprises realize compliant and efficient production and grow into a trustworthy domestic service provider.
Equipment selection is a long-term strategic investment for biopharmaceutical enterprises. Manufacturers shall follow industrial trends, make choices based on practical demands, and select qualified, mature and well-supported products to cut costs, improve efficiency and achieve high-quality development under safe and compliant production conditions.
ReviewsNumber of comments: {{ page.total }}
I want to comment?
{{item.nickname ? (item.nickname.slice(0, 2) + '*****') : item.source === 1 ? 'mall buyer' : '--'}}
{{item.comment_time}}
Review in the {{item.country}}
Reviews
Merchant
{{replyItem.nickname ? (replyItem.nickname.slice(0, 2) + '*****') : replyItem.source === 1 ? 'mall buyer' : '--'}}
{{replyItem.parent_nickname ? (replyItem.parent_nickname.slice(0, 2) + '*****') : '--'}}
{{replyItem.is_merchant_reply === 1 ? replyItem.reply_time : replyItem.comment_time}}
Review in the {{replyItem.country}}
Reviews
No customer reviews
recommended for you
Get in touch with us
+86 13354196886
Ly Sinobiz Machinery Co., Ltd.
Welcome to LY SINOBIZ MACHINERY CO., LTD- a world-leading health care product machinery and pharmaceutical packaging machinery technology enterprise committed to innovation, excellence and sustainable development. Our mission is to make the world a better place through our technology and services.
Shortcut links
Packaging Machinery
Contact with us
Contact Person: Long Yang
Contact Number: +8613354196886
Email: davidhe@lyzw.cc
WhatsApp: +8613354196886
Company Address: Xiexi Industry Zone, Liaoyang City, Liaoning Province